US Patent Issued to BIOMARIN PHARMACEUTICAL, Yale University on Aug. 4 for "Soluble ENPP1 proteins and uses thereof" (Connecticut, Florida, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,487, issued on Aug. 4, was assigned to BIOMARIN PHARMACEUTICAL INC. (Novato, Calif.) and Yale University (New Haven, Conn.).

"Soluble ENPP1 proteins and uses thereof" was invented by Zhiliang Cheng (Boston), Demetrios Braddock (Guilford, Conn.), Paul Stabach (New Haven, Conn.) and Steven Jungles (Key West, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain aspects, the present invention provides novel soluble ENPP1 or ENPP3 polypeptides, as well as compositions and methods for using those variants to treat an indication associated an ENPP1 or ENPP3 deficiency. The compositions and methods provided herein are useful in treating diseases as...